Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | 1 | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | 1 | 1 | — | — | — | 1 |
Adenocarcinoma | D000230 | — | — | 1 | 1 | — | — | — | 1 |
Drug common name | VACTOSERTIB |
INN | vactosertib |
Description | Vactosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against activin receptor type-1B and TGF-beta receptor type-1. |
Classification | Small molecule |
Drug class | serine/threonine kinase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1 |
PDB | — |
CAS-ID | 1352608-82-2 |
RxCUI | — |
ChEMBL ID | CHEMBL3260567 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6T4O391P5Y (ChemIDplus, GSRS) |